Den offentliggjorte undersøgelse viste, at patienter, der fik kombinationsbehandling med Xeloda, overlevede lige så længe som dem, der fik kombinationsbehandling med 5- FU.
The published study showed that patients taking combinations of medicines that included Xeloda survived for a similar length of time as those taking combinations including 5-FU.